Cannabis-Based drug trial offers new hope for sickle cell pain
NCT ID NCT05519111
Summary
This study is testing whether dronabinol, a medication derived from cannabis, can help reduce chronic pain and inflammation in adults with sickle cell disease. Researchers will compare dronabinol to a placebo (inactive pill) in 60 participants to see if it improves pain levels and quality of life. The trial will also check if the treatment is safe and well-tolerated for people with this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
RECRUITINGNew York, New York, 10029, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.